Yes, Fleet Enema Can Cause Acute Kidney Injury
Fleet enema (sodium phosphate) is a well-documented cause of acute kidney injury and should be used with extreme caution or avoided entirely in high-risk patients, particularly the elderly, those with pre-existing kidney disease, bowel disorders, or poor gut motility.
Mechanism of Kidney Injury
Sodium phosphate enemas cause AKI through two primary mechanisms 1:
- Direct tubular injury: Absorbed phosphate leads to calcium-phosphate crystal deposition within renal tubular lumens, causing acute phosphate nephropathy (APN)
- Severe metabolic derangements: Extreme hyperphosphatemia triggers hypocalcemia, which can result in cardiovascular collapse and secondary ischemic kidney injury
Clinical Evidence of Harm
The evidence for sodium phosphate-induced kidney injury is substantial and alarming:
Single-center case series 2 reported 11 elderly patients who received Fleet enemas for constipation, with devastating outcomes:
- All 11 patients developed acute renal failure
- Extreme hyperphosphatemia (phosphorus 5.3-45.0 mg/dL) and severe hypocalcemia (calcium 2.0-8.7 mg/dL)
- 45% mortality rate (5 of 11 patients died)
- Autopsy confirmed calcium-phosphate deposition in renal tubular lumens
- Most presented within 24 hours with hypotension and volume depletion
Systematic review 3 covering 2005-2021 identified:
- 7 adult deaths from phosphate enema toxicity
- Common presentations: hypotension, decreased consciousness, tetany, QT prolongation
- Even standard 250-mL doses caused severe complications
- Hemodialysis failed to prevent death in 2 of 4 adult cases where it was used
Recent clinicopathological analysis 4 of 517 kidney biopsies (2017-2022):
- 9 patients diagnosed with APN following oral sodium phosphate bowel preparation
- All developed chronic kidney disease over time
- One progressed to end-stage renal disease requiring dialysis
- Von Kossa staining confirmed calcium phosphate deposition in all cases
High-Risk Patient Groups
Absolute contraindications or extreme caution warranted in 2, 3, 5:
- Elderly patients (most deaths occurred in this group)
- Pre-existing chronic kidney disease or renal impairment
- Bowel obstruction or poor gut motility (increases retention time and absorption)
- Hirschsprung disease in children
- Small intestinal disorders
- Dehydration or volume depletion
Critical Pitfalls
- Standard doses are NOT safe: Even the recommended 250-mL dose caused fatal complications 2
- Rapid onset: Most patients presented within 24 hours of administration
- Irreversible damage: Many survivors developed permanent chronic kidney disease 4
- Over-the-counter availability: The FDA label 6 warns against using more than one enema in 24 hours but does not adequately convey the severity of potential kidney injury
Risk Mitigation Strategy
Following KDIGO principles on nephrotoxic medication management 1:
Primary recommendation: Use alternative enema preparations that do not contain absorbable ions:
- Simple tap water enemas
- Saline solution enemas
- Non-phosphate osmotic preparations
If phosphate enema must be used (which should be rare):
- Screen for all risk factors listed above
- Ensure adequate hydration before and after administration
- Use only single standard dose (never exceed)
- Monitor serum phosphate, calcium, and creatinine within 24-48 hours in high-risk patients
- Educate patients about signs of toxicity: confusion, tetany, severe weakness, decreased urine output
Institutional Response
One hospital's educational campaign reduced Fleet enema use by 96% after recognizing the severe complications 2, demonstrating that safer alternatives can effectively replace sodium phosphate enemas in routine practice.
The evidence clearly demonstrates that sodium phosphate enemas cause acute kidney injury with significant morbidity and mortality, particularly in vulnerable populations. Alternative bowel preparations should be strongly preferred.